Paclitaxel Drug Market

Paclitaxel?(PTX), sold under the brand name Taxol among others, is a chemotherapy?medication?used to treat a number of types of cancer.?
Paclitaxel Drug Market contains market size and forecasts of Paclitaxel Drug in global, including the following market information:
Global Paclitaxel Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Paclitaxel Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Paclitaxel Drug companies in 2021 (%)
The global Paclitaxel Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paclitaxel Drug include Luye Pharma, CSPC Company, Celgene, Jiangsu Hengrui, Bristol-Myers Squibb, Pfizer, Teva, Mylan and Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paclitaxel Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paclitaxel Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paclitaxel Drug Market Segment Percentages, by Type, 2021 (%)
30mg
100mg
Global Paclitaxel Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paclitaxel Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Drugs Store
Global Paclitaxel Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paclitaxel Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paclitaxel Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Paclitaxel Drug revenues share in global market, 2021 (%)
Key companies Paclitaxel Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Paclitaxel Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Luye Pharma
CSPC Company
Celgene
Jiangsu Hengrui
Bristol-Myers Squibb
Pfizer
Teva
Mylan
Novartis